These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7163667)

  • 1. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of combined immunosuppressive treatment with Imuran and prednisone on the concentration of selected immune proteins in the serum of patients with lupus erythematosus].
    Chwal Z
    Pol Tyg Lek; 1976 May; 31(16):659-61. PubMed ID: 1083976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Remote results of combined immunosuppressive treatment of systemic lupus erythematosus (1969-1978)].
    Wysocka K; Kiczak J; Hawrlylak E
    Wiad Lek; 1979 Nov; 32(22):1591-4. PubMed ID: 538910
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 5. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1982; 20(3-4):137-42. PubMed ID: 7187069
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serum complements and circulating immune complex in patients with systemic lupus erythematosus].
    Tang HY
    Zhonghua Yi Xue Za Zhi; 1983 Feb; 63(2):83-6. PubMed ID: 6407735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
    Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
    Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
    [No Abstract]   [Full Text] [Related]  

  • 9. [The significance of immuno-biologic parameters during and in the prognosis of patients with systemic lupus erythematosus].
    Ljaljević M; Ljaljević J; Zlatković Lj; Latković J
    Glas Srp Akad Nauka Med; 1982; (35):111-20. PubMed ID: 7182242
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of systemic lupus erythematosus in childhood.
    Jacobs JC
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):304-7. PubMed ID: 318122
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of treatment of lupus nephropathy.
    Coggins CH
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute transverse myelitis in systemic lupus erythematosus: successful therapy with cyclophosphamide and prednisone].
    Misteli M; Conen D
    Schweiz Med Wochenschr; 1991 Jan; 121(3):77-80. PubMed ID: 1992504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute polyvisceral lupus erythematosus in a young 12-year-old girl. The value of plasma exchange].
    Palcoux JB; de Champs C; Roche M; Vanlieferinghen P
    Pediatrie; 1983 Mar; 38(2):119-23. PubMed ID: 6622140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967 Dec; 34(1):5-22. PubMed ID: 4173836
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of circulating immune complexes in systemic lupus erythematosus by the method of conglutinin and monoclonal rheumatoid factor].
    de Oliveira RM; Marchiori PE; Viana Vdos S; Bueno C; dos Reis M; Quevedo ME; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(1):6-9. PubMed ID: 4059787
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of bemetil on the production of DNA antibodies in patients with systemic lupus erythematosus].
    Lisitsyna TA; Durnev AD; Ivanova MM; Speranskiĭ AI; Seredenin SB; Nasonova VA
    Eksp Klin Farmakol; 1999; 62(5):38-41. PubMed ID: 10572751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relation between immune complexes, anti-DNA antibodies and complement in lupus nephropathy].
    Pastore A; Manno C; Losuriello V; Vox E; Schena FP
    Minerva Nefrol; 1981; 28(4):503-8. PubMed ID: 7339520
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M; Graninger WB; Steiner G; Smolen JS
    Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.